Besponsa Interactions
There are 422 drugs known to interact with Besponsa (inotuzumab ozogamicin), along with 3 disease interactions. Of the total drug interactions, 109 are major, 312 are moderate, and 1 is minor.
- View all 422 medications that may interact with Besponsa
- View Besponsa disease interactions (3)
Most frequently checked interactions
View interaction reports for Besponsa (inotuzumab ozogamicin) and the medicines listed below.
- Adcetris (brentuximab)
- Adriamycin RDF (doxorubicin)
- bleomycin
- Blincyto (blinatumomab)
- CellCept (mycophenolate mofetil)
- Corlanor (ivabradine)
- Cosentyx (secukinumab)
- Elaprase (idursulfase)
- Empliciti (elotuzumab)
- Enbrel (etanercept)
- etoposide
- Exjade (deferasirox)
- Imbruvica (ibrutinib)
- Kalydeco (ivacaftor)
- Kineret (anakinra)
- Kynamro (mipomersen)
- Matulane (procarbazine)
- Norvir (ritonavir)
- Ocrevus (ocrelizumab)
- Oncovin (vincristine)
- Orfadin (nitisinone)
- prednisone
- Procysbi (cysteamine)
- Promacta (eltrombopag)
- Ravicti (glycerol phenylbutyrate)
- Repatha (evolocumab)
- Rescriptor (delavirdine)
- Simulect (basiliximab)
- Stivarga (regorafenib)
- Tecentriq (atezolizumab)
Besponsa disease interactions
There are 3 disease interactions with Besponsa (inotuzumab ozogamicin) which include:
More about Besponsa (inotuzumab ozogamicin)
- Besponsa consumer information
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: miscellaneous antineoplastics
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.